NYSCF Investigator Looks To Animal Genomes To Learn More About Human Disease
Elephants don’t get cancer. Well, they do, but not nearly at the same rate as other mammals. In a way, this is odd because cancer is...
82 Results
Clear Filters
CRISPR Gets A New Skill: Diagnosing Disease
CRISPR is everywhere. There’s so much work being done with this revolutionary gene-editing tool that it warrants its own journal. And researchers are still finding new...
The Adventures of Pioneer Factors
The DNA in each of our cells is identical, but not every cell expresses it in the same way. Genes are expressed in different ways at...
Unraveling The Mystery Of Our Scrunched-Up DNA
A group of researchers at the University of Pennsylvania led by NYSCF — Robertson Investigator Jennifer Phillips-Cremins, PhD, have developed a tool to examine why the physical...
2017 Year in Review
As we enter 2018, NYSCF is taking a moment to look back on the milestones of 2017. With your support, we accelerated our research, began new...
NYSCF Innovator Improves CRISPR Genome Repair
CRISPR is a revolutionary gene-editing technology that has many potential applications in medicine. Derrick Rossi, PhD, Associate Professor at Harvard University and NYSCF – Robertson Investigator...
New CRISPR Target: RNA
NYSCF – Robertson Stem Cell Investigator and NYSCF – Robertson Stem Cell Prize recipient Feng Zhang, PhD, Core Member of the Broad Institute of Harvard and...
CRISPR Gene Editing Technology Enables Novel RNA Research
NYSCF – Robertson Stem Cell Investigator and NYSCF – Robertson Stem Cell Prize Awardee Dr. Feng Zhang and his team at the Broad Institute of Harvard...
NYSCF Innovator Uses Gene Editing Technology to Screen Deadly Brain Cancer for Weaknesses
NYSCF – Robertson Stem Cell Investigator and NYSCF – Robertson Stem Cell Prize Awardee Dr. Feng Zhang and his team at the Broad Institute of Harvard and MIT...
NYSCF Innovator Feng Zhang Investigates the Role of Genetic Diversity in Future Gene Editing Treatments
The possibilities and implications of utilizing gene editing technology to treat patients raise thorny questions that must be addressed in a careful and thorough research and...
NYSCF Innovator Describes Potential Cell Replacement Strategy for Parkinson’s Disease
The traditional cell replacement therapy model relies on manufacturing the relevant cell type in the lab and injecting or replacing these cells into the patient, curing...
Five Women Unite to Crack the Code of Multiple Sclerosis
In a collaborative tour de force, five female principal investigators, including NYSCF’s own Dr. Valentina Fossati, are uncovering the cellular mechanisms behind multiple sclerosis (MS). Over...
New Tools for Simultaneous, Multi-Gene Editing
NYSCF – Robertson Stem Cell Investigator and NYSCF – Robertson Stem Cell Prize Awardee Dr. Feng Zhang, the Broad Institute of Harvard and MIT, published his latest...
Feng Zhang Receives 2016 NYSCF – Robertson Stem Cell Prize
NYSCF announced today that Feng Zhang, PhD, is the 2016 recipient of the NYSCF – Robertson Stem Cell Prize for his pioneering advances to edit human...
Partnering to Accelerate Alzheimer’s Research
The NYSCF Research Institute is committed to accelerating research by sharing its expertise and leveraging its technologies with scientists at collaborating institutions around the world. A...
NYSCF – Robertson Investigator Feng Zhang Receives 2016 Canada Gairdner Award
NYSCF – Robertson Investigator Dr. Feng Zhang received the 2016 Canada Gairdner Award for his work developing revolutionary tools to edit DNA in establishing and enhancing...
NYSCF – Robertson Investigator Feng Zhang Engineers Protein to Enhance DNA Editing
NYSCF – Robertson Investigator Dr. Feng Zhang pioneered technology to edit DNA. The system he created, CRISPR/Cas9, means scientists can now study disease, cures, and cellular...
NYSCF – Robertson Investigator Discovers New Proteins to Edit DNA
As NYSCF – Robertson Investigator Feng Zhang, Broad Institute of Harvard and MIT, explained at The NYSCF Conference, “Nature is smarter than us.” Dr. Zhang’s lab...
NYSCF – Robertson Investigator Studies Genetic Imprinting
NYSCF – Robertson Neuroscience Investigator Dr. Christopher Gregg, University of Utah, published his latest work on parental genetic imprinting in mice. The research, published in Cell...
NYSCF – Robertson Investigator Advances Genome Editing Technique
NYSCF – Robertson Stem Cell Investigator Dr. Feng Zhang, Broad Institute of Harvard and MIT, created a smaller molecule for specific genome editing. A commonly used...
NYSCF – Robertson Investigator Publishes Latest on DNA Methylation
NYSCF – Robertson Stem Cell Investigator Dr. Alex Meissner, Harvard Universtiy, publsihed his latest work studying DNA methylation patterns in Nature Genetics. Dr. Meissner and his...
NYSCF – Robertson Investigator Advances New Strategies for Tumor Genome Mapping
NYSCF – Robertson Stem Cell Investigator Dr. Feng Zhang, Broad Institute of MIT and Harvard, used a gene editing technology called CRISPR/Cas-9 mediated loss-of-function screen to conduct...
NYSCF – Robertson Investigator Makes Progress in Genome Editing
NYSCF – Robertson Stem Cell Investigator Dr. Feng Zhang, Broad Institute of MIT and Harvard, published his latest work on genome editing in Nature Biotechnology. Dr....
NYSCF – Robertson Investigator Gains Insight Into Cancer Adaption
NYSCF – Robertson Stem Cell Investigator Dr. Alex Meissner, Harvard University, analyzed the genetic patterns in cancer cells and found that disarray in the cellular on-off...
NYSCF Speaks on “Homo Sapiens: 2.0” Panel at 92nd Street Y
The 92nd Street Y in Manhattan hosted a panel discussion entitled, “Homo Sapiens 2.0: Genetic Enhancement and the Future of Humanity,” which covered current and future...